ANI
About
Technology stack
detected 2026-07-16No comments yet. Be the first to share your take.
What does ANI do?
ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company committed to developing, manufacturing, and commercializing innovative and high-quality therapeutics. They are transforming into a leading Rare Disease company, with a focus on ophthalmology, rheumatology, nephrology, neurology, and pulmonology, alongside a strong Generics business leveraging R&D expertise and U.S.-based manufacturing.
How much funding has ANI raised?
ANI has raised a total of $3.4B in funding. The most recent round on record is Seed.
Where is ANI headquartered?
ANI is headquartered in Princeton, United States.
When was ANI founded?
ANI was founded in 1981.
What industry does ANI operate in?
ANI operates in Biopharmaceutical, Rare Disease, Ophthalmology, Generics, Drug Discovery, Manufacturing.
How many employees does ANI have?
ANI has approximately 710 people on record.
What is ANI's valuation?
StartupHub estimates ANI's effective valuation at $15.1B (range $8.6B to $20.6B, 19% confidence), based on comparable companies in the sector.